Haleon PLC
Company Profile
Business description
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon’s brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Contact
The Heights
Building 5, First Floor
Surrey
WeybridgeKT13 0NY
GBRT: +44 1932959500
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
24,622
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,820.30 | 6.40 | -0.07% |
CAC 40 | 7,828.78 | 73.47 | -0.93% |
DAX 40 | 24,265.12 | 191.69 | -0.78% |
Dow JONES (US) | 44,416.92 | 233.72 | -0.52% |
FTSE 100 | 8,940.91 | 34.75 | -0.39% |
HKSE | 24,139.57 | 111.20 | 0.46% |
NASDAQ | 20,625.93 | 4.74 | -0.02% |
Nikkei 225 | 39,569.68 | 76.68 | -0.19% |
NZX 50 Index | 12,686.68 | 73.52 | -0.58% |
S&P 500 | 6,262.05 | 18.41 | -0.29% |
S&P/ASX 200 | 8,580.10 | 9.10 | -0.11% |
SSE Composite Index | 3,510.18 | 0.50 | 0.01% |